Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

Volume 16 Issue 4, April 2016

'New colonies' by Lara Crow, inspired by the Review on p201.

Research Highlight

  • Two studies inScience report that co-deletion of MTAP — which is common in CDKN2A-deleted cancers — is not a silent passenger event but renders cells sensitive to inhibition of protein arginine methyltransferase 5 (PRMT5), a dependency that could be therapeutically targeted in MTAP-deleted cancers.

    • Lydia Shipman
    Research Highlight

    Advertisement

  • Two papers assess the role of glucose in lung cancer metabolismin vivo.

    • Gemma K. Alderton
    Research Highlight
  • Enriquez-Navaset al. show that an evolution-based adaptive treatment strategy is more effective than standard therapy for controlling tumour growth in orthotopic xenograft mouse models of breast cancer.

    • Sarah Seton-Rogers
    Research Highlight
Top of page ⤴

In Brief

Top of page ⤴

Review Article

  • Tumour metastasis is a major contributor to the mortality of cancer patients, so why is this phase of cancer pathogenesis not routinely targeted? This Review discusses the possible strategies — including preclinical research, combination therapies and clinical trial designs — that could be developed to target metastasis.

    • Patricia S. Steeg
    Review Article
  • This Review summarizes immune evasion mechanisms that limit the therapeutic efficacy of cancer vaccines. The authors discuss how improving vaccine design and using vaccines in combination with other anticancer therapies can boost treatment efficacy in patients with established cancers.

    • Sjoerd H. van der Burg
    • Ramon Arens
    • Cornelis J. M. Melief
    Review Article
  • This Review discusses technological and biologically based advances in radiotherapy. The authors envisage that these two major strategies will act synergistically to further widen the therapeutic window of radiation oncology in the era of precision medicine.

    • Michael Baumann
    • Mechthild Krause
    • Thomas Bortfeld
    Review Article
Top of page ⤴

Analysis

  • Using genomic data, this Analysis demonstrates that commonly inherited single nucleotide polymorphisms (SNPs) occurring in genes of the p53 pathway affect the incidence of a broad range of cancers, more so than SNPs in other pathways. This has implications for p53-mediated tumour suppression in humans.

    • Giovanni Stracquadanio
    • Xuting Wang
    • Gareth L. Bond
    Analysis
Top of page ⤴

Opinion

  • Current cancer therapies exert selective pressures that drive the evolution of drug-resistant clones. In this Opinion article, the authors argue that induction of stable tumour reversion represents an alternative strategy that could reduce resistance and thus effectively and durably treat cancer.

    • Scott Powers
    • Robert E. Pollack
    Opinion
Top of page ⤴

Search

Quick links